Biogen's MS drug in question

Biogen's MS drug in question

There are 1 comment on the Investor's Business Daily story from Jul 15, 2011, titled Biogen's MS drug in question. In it, Investor's Business Daily reports that:

Twelve more cases of a rare brain infection occurred in multiple-sclerosis patients taking the biotech's drug Tysabri, which it sells with Elan , bringing the number of affected patients to 145.

Join the discussion below, or Read more at Investor's Business Daily.

gumby

West Palm Beach, FL

#1 Jul 16, 2011
Lets stop pushing poison. Docs wouldn't take it. F--- big drug companies. CCSVI, healthy diet and pt.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Elan Corporation Plc Discussions

Title Updated Last By Comments
News Drugmaker Elan plans to explore sale of company (Jun '13) Jun '13 HumanSpirit 1
News Plavix deal stokes pharma stocks; Biogen, Elan ... (Apr '06) May '13 Yadiel 5
News IPO Preview: ChemoCentryx (May '12) May '12 Robson 1
News Neuroimaging Technique Supports Reduction in Am... (Mar '10) Mar '10 sophia brown 1
News Patients taking Tysabri report improvement in p... (Sep '09) Sep '09 tysabri_ftl 1
News ''Step Inside MS'' National Tour Brings First-o... (Sep '07) Sep '07 Michelle 3
share_prince Mar '06 jjj 1
More from around the web